-
A Bayesian approach for fitting semi-Markov mixture models of cancer latency to individual-level data
Authors:
Raphael Morsomme,
Shannon Holloway,
Marc Ryser,
Jason Xu
Abstract:
Multi-state models of cancer natural history are widely used for designing and evaluating cancer early detection strategies. Calibrating such models against longitudinal data from screened cohorts is challenging, especially when fitting non-Markovian mixture models against individual-level data. Here, we consider a family of semi-Markov mixture models of cancer natural history introduce an efficie…
▽ More
Multi-state models of cancer natural history are widely used for designing and evaluating cancer early detection strategies. Calibrating such models against longitudinal data from screened cohorts is challenging, especially when fitting non-Markovian mixture models against individual-level data. Here, we consider a family of semi-Markov mixture models of cancer natural history introduce an efficient data-augmented Markov chain Monte Carlo sampling algorithm for fitting these models to individual-level screening and cancer diagnosis histories. Our fully Bayesian approach supports rigorous uncertainty quantification and model selection through leave-one-out cross-validation, and it enables the estimation of screening-related overdiagnosis rates. We demonstrate the effectiveness of our approach using synthetic data, showing that the sampling algorithm efficiently explores the joint posterior distribution of model parameters and latent variables. Finally, we apply our method to data from the US Breast Cancer Surveillance Consortium and estimate the extent of breast cancer overdiagnosis associated with mammography screening. The sampler and model comparison method are available in the R package baclava.
△ Less
Submitted 26 August, 2024;
originally announced August 2024.
-
Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial
Authors:
Anastasios A. Tsiatis,
Marie Davidian,
Shannon T. Holloway
Abstract:
In many randomized clinical trials of therapeutics for COVID-19, the primary outcome is an ordinal categorical variable, and interest focuses on the odds ratio (active agent vs. control) under the assumption of a proportional odds model. Although at the final analysis the outcome will be determined for all subjects, at an interim analysis, the status of some participants may not yet be determined,…
▽ More
In many randomized clinical trials of therapeutics for COVID-19, the primary outcome is an ordinal categorical variable, and interest focuses on the odds ratio (active agent vs. control) under the assumption of a proportional odds model. Although at the final analysis the outcome will be determined for all subjects, at an interim analysis, the status of some participants may not yet be determined, e.g., because ascertainment of the outcome may not be possible until some pre-specified follow-up time. Accordingly, the outcome from these subjects can be viewed as censored. A valid interim analysis can be based on data only from those subjects with full follow up; however, this approach is inefficient, as it does not exploit additional information that may be available on those for whom the outcome is not yet available at the time of the interim analysis. Appealing to the theory of semiparametrics, we propose an estimator for the odds ratio in a proportional odds model with censored, time-lagged categorical outcome that incorporates additional baseline and time-dependent covariate information and demonstrate that it can result in considerable gains in efficiency relative to simpler approaches. A byproduct of the approach is a covariate-adjusted estimator for the odds ratio based on the full data that would be available at a final analysis.
△ Less
Submitted 24 August, 2021; v1 submitted 29 June, 2021;
originally announced June 2021.
-
Multi-stage optimal dynamic treatment regimes for survival outcomes with dependent censoring
Authors:
Hunyong Cho,
Shannon T. Holloway,
David J. Couper,
Michael R. Kosorok
Abstract:
We propose a reinforcement learning method for estimating an optimal dynamic treatment regime for survival outcomes with dependent censoring. The estimator allows the failure time to be conditionally independent of censoring and dependent on the treatment decision times, supports a flexible number of treatment arms and treatment stages, and can maximize either the mean survival time or the surviva…
▽ More
We propose a reinforcement learning method for estimating an optimal dynamic treatment regime for survival outcomes with dependent censoring. The estimator allows the failure time to be conditionally independent of censoring and dependent on the treatment decision times, supports a flexible number of treatment arms and treatment stages, and can maximize either the mean survival time or the survival probability at a certain time point. The estimator is constructed using generalized random survival forests and can have polynomial rates of convergence. Simulations and data analysis results suggest that the new estimator brings higher expected outcomes than existing methods in various settings. An R package dtrSurv is available on CRAN.
△ Less
Submitted 12 May, 2022; v1 submitted 6 December, 2020;
originally announced December 2020.
